Market Overview
The global Riboflavin Corneal Crosslinking Market was valued at USD 185.0 million in 2025 and is estimated to reach USD 200.7 million in 2026. The market is projected to grow to USD 385.0 million by 2034, registering a CAGR of 8.5% during 2026–2034.
Riboflavin, also known as vitamin B2, is used in ultraviolet-A (UVA)-activated corneal collagen crosslinking...
